Testosterone Cream for Women — Women's Hormones
Transdermal testosterone therapy for sexual dysfunction and quality of life in perimenopausal and postmenopausal women. Grade B evidence from multiple RCTs.
Overview
Testosterone therapy in women addresses symptoms of androgen deficiency including low libido, fatigue, decreased motivation, and cognitive fog. The Global Consensus Position Statement (2019) and Cochrane Review (2020) of 36 RCTs (8,480 women) support testosterone for postmenopausal women with hypoactive sexual desire disorder (HSDD). Transdermal cream is preferred over oral or injectable routes. While not FDA-approved for women in the US, testosterone is widely used off-label with endorsement from international menopause societies.
Indications
- Hypoactive Sexual Desire Disorder (HSDD) in peri/postmenopausal women
- Low libido unresponsive to estrogen therapy alone
- Fatigue and decreased energy in menopause
- Cognitive symptoms (brain fog) during menopause transition
- Decreased motivation and sense of well-being
Mechanism of Action
Testosterone cream absorbed through skin, bypassing hepatic first-pass metabolism
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Compounded Testosterone Cream | 0.5 mg/day | Apply daily | Starting dose. Apply to inner thigh, labia majora, or forearm. Compounded 0.5% cream |
| Compounded Testosterone Cream | 1.0 mg/day | Apply daily | Typical therapeutic dose. 1% cream (1mg per 0.1mL application) |
| Compounded Testosterone Cream | 2.0 mg/day | Apply daily | Upper limit for physiologic replacement. Rarely needed; monitor for androgenic effects |
Evidence Grade
GRADE B
Safety & Contraindications
- NOT FDA-approved for women - off-label use supported by international guidelines
- Transdermal cream preferred over oral (avoid first-pass liver metabolism)
- Monitor for androgenic effects: acne, hirsutism, voice deepening (rare at physiologic doses)
- Aim for premenopausal female testosterone levels, NOT supraphysiologic
- Contraindicated with active breast cancer, pregnancy, or androgen-sensitive conditions
- Use in conjunction with estrogen/progesterone HRT for best results
- Long-term safety data (>2 years) limited but reassuring short-term profiles